{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:04:18Z","timestamp":1766181858650,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K09444"],"award-info":[{"award-number":["18K09444"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41433-022-02067-6","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T10:02:54Z","timestamp":1649930574000},"page":"1067-1072","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Macular atrophy at 5 years after photodynamic therapy for polypoidal choroidal vasculopathy"],"prefix":"10.1038","volume":"37","author":[{"given":"Kentaro","family":"Kawai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7574-1749","authenticated-orcid":false,"given":"Manabu","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotaro","family":"Ooto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-2732","authenticated-orcid":false,"given":"Hiroshi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Ueda-Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Uji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9354-8558","authenticated-orcid":false,"given":"Kenji","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitaka","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"2067_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","volume":"10","author":"LA Yannuzzi","year":"1990","unstructured":"Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990;10:1\u20138.","journal-title":"Retina"},{"key":"2067_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/bjo.86.3.321","volume":"86","author":"H Terasaki","year":"2002","unstructured":"Terasaki H, Miyake Y, Suzuki T, Nakamura M, Nagasaka T. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol. 2002;86:321\u20137.","journal-title":"Br J Ophthalmol"},{"key":"2067_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/bjo.2003.032466","volume":"88","author":"M Matsuoka","year":"2004","unstructured":"Matsuoka M, Ogata N, Otsuji T, Nishimura T, Takahashi K, Matsumura M. Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol. 2004;88:809\u201315.","journal-title":"Br J Ophthalmol"},{"key":"2067_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00417-014-2688-1","volume":"253","author":"M Hata","year":"2015","unstructured":"Hata M, Tsujikawa A, Miyake M, Yamashiro K, Ooto S, Oishi A, et al. Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Graefe\u2019s Arch Clin Exp Ophthalmol. 2015;253:221\u20137.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"2067_CR5","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s00417-020-04710-y","volume":"258","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kim JW, Kim CG, Lee DW. Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Graefe\u2019s Arch Clin Exp Ophthalmol. 2020;258:1677\u201385.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"2067_CR6","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.ophtha.2015.05.024","volume":"122","author":"A Yamamoto","year":"2015","unstructured":"Yamamoto A, Okada AA, Kano M, Koizumi H, Saito M, Maruko I, et al. One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy. Ophthalmology 2015;122:1866\u201372.","journal-title":"Ophthalmology"},{"key":"2067_CR7","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.ophtha.2003.12.056","volume":"111","author":"W-M Chan","year":"2004","unstructured":"Chan W-M, Lam DSC, Lai TYY, Liu DTL, Li KKW, Yao Y, et al. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology 2004;111:1576\u201384.","journal-title":"Ophthalmology"},{"key":"2067_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ophtha.2007.02.031","volume":"115","author":"F Gomi","year":"2008","unstructured":"Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, et al. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2008;115:141\u20136.","journal-title":"Ophthalmology"},{"key":"2067_CR9","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/IAE.0b013e31820d3f3f","volume":"31","author":"TYY Lai","year":"2011","unstructured":"Lai TYY, Lee GKY, Luk FOJ, Lam DSC. Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy. Retina 2011;31:1581\u20138.","journal-title":"Retina"},{"key":"2067_CR10","doi-asserted-by":"publisher","first-page":"e0176100","DOI":"10.1371\/journal.pone.0176100","volume":"12","author":"K Takayama","year":"2017","unstructured":"Takayama K, Kaneko H, Kataoka K, Hattori K, Ra E, Tsunekawa T, et al. Comparison between 1-year outcomes of aflibercept with and without photodynamic therapy for polypoidal choroidal vasculopathy: Retrospective observation study. PLoS ONE. 2017;12:e0176100.","journal-title":"PLoS ONE"},{"key":"2067_CR11","first-page":"835","volume":"120","author":"U Schmidt-Erfurth","year":"2002","unstructured":"Schmidt-Erfurth U, Laqua H, Schl\u00f6tzer-Schrehard U, Viestenz A, Naumann GOH. Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol. 2002;120:835\u201344.","journal-title":"Arch Ophthalmol"},{"key":"2067_CR12","first-page":"830","volume":"43","author":"U Schmidt-Erfurth","year":"2002","unstructured":"Schmidt-Erfurth U, Michels S, Barbazetto I, Laqua H. Photodynamic effects on choroidal neovascularization and physiological choroid. Investig Ophthalmol Vis Sci. 2002;43:830\u201341.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2067_CR13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/bjophthalmol-2018-311963","volume":"103","author":"M Miyata","year":"2019","unstructured":"Miyata M, Ooto S, Yamashiro K, Tamura H, Hata M, Ueda-Arakawa N, et al. Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy. Br J Ophthalmol. 2019;103:617\u201322.","journal-title":"Br J Ophthalmol"},{"key":"2067_CR14","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1136\/bjophthalmol-2019-315496","volume":"104","author":"HJ Cho","year":"2020","unstructured":"Cho HJ, Kim K, Lim SH, Kang DH, Kim JW. Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. Br J Ophthalmol. 2020;104:1443\u20137.","journal-title":"Br J Ophthalmol"},{"key":"2067_CR15","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1097\/IAE.0000000000001059","volume":"36","author":"NS Abdelfattah","year":"2016","unstructured":"Abdelfattah NS, Zhang H, Boyer DS, Sadda SR. Progression of macular atrophy in patients with neovascular age-related macular degeneration undergoing antivascular endothelial growth factor therapy. Retina 2016;36:1843\u201350.","journal-title":"Retina"},{"key":"2067_CR16","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/IAE.0000000000001765","volume":"38","author":"Y Kuroda","year":"2018","unstructured":"Kuroda Y, Yamashiro K, Ooto S, Tamura H, Oishi A, Nakanishi H, et al. Macular atrophy and macular morphology in aflibercept-treated neovascular age-related macular degeneration. Retina 2018;38:1743\u201350.","journal-title":"Retina"},{"key":"2067_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ajo.2015.09.032","volume":"161","author":"Y Kuroda","year":"2016","unstructured":"Kuroda Y, Yamashiro K, Tsujikawa A, Ooto S, Tamura H, Oishi A, et al. Retinal pigment epithelial atrophy in neovascular age-related macular degeneration after ranibizumab treatment. Am J Ophthalmol. 2016;161:94\u2013103.","journal-title":"Am J Ophthalmol"},{"key":"2067_CR18","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/IAE.0000000000001457","volume":"37","author":"M Hata","year":"2017","unstructured":"Hata M, Yamashiro K, Oishi A, Ooto S, Tamura H, Miyata M, et al. Retinal pigment epithelial atrophy after anti\u2013vascular endothelial growth factor injections for retinal angiomatous proliferation. Retina 2017;37:2069\u201377.","journal-title":"Retina"},{"key":"2067_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0237-x","volume":"16","author":"T Hikichi","year":"2016","unstructured":"Hikichi T, Kitamei H, Shioya S. Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy. BMC Ophthalmol. 2016;16:55 https:\/\/doi.org\/10.1186\/s12886-016-0237-x","journal-title":"BMC Ophthalmol"},{"key":"2067_CR20","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ophtha.2010.09.012","volume":"118","author":"SE Chung","year":"2011","unstructured":"Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 2011;118:840\u20135.","journal-title":"Ophthalmology"},{"key":"2067_CR21","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1097\/IAE.0b013e31821801c5","volume":"31","author":"S-W Kim","year":"2011","unstructured":"Kim S-W, Oh J, Kwon S-S, Yoo J, Huh K. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy. Retina 2011;31:1904\u201311.","journal-title":"Retina"},{"key":"2067_CR22","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1167\/iovs.11-8353","volume":"52","author":"KM Ford","year":"2011","unstructured":"Ford KM, Saint-Geniez M, Walshe T, Zahr A, D\u2019Amore PA. Expression and role of VEGF in the adult retinal pigment epithelium. Investig Ophthalmol Vis Sci. 2011;52:9478\u201387.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2067_CR23","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ophtha.2017.12.026","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda SR, Tuomi LL, Ding B, Fung AE, Hopkins JJ. Macular atrophy in the HARBOR study for neovascular age-related macular degeneration. Ophthalmology 2018;125:878\u201386.","journal-title":"Ophthalmology"},{"key":"2067_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta19780","volume":"19","author":"U Chakravarthy","year":"2015","unstructured":"Chakravarthy U, Harding SP, Rogers CA, Downes S, Lotery AJ, Dakin HA, et al. A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN). Health Technol Assess. 2015;19:1.","journal-title":"Health Technol Assess"},{"key":"2067_CR25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ophtha.2019.11.010","volume":"127","author":"SR Sadda","year":"2020","unstructured":"Sadda SR, Guymer R, Mon\u00e9s JM, Tufail A, Jaffe GJ. Anti\u2013vascular endothelial growth factor use and atrophy in neovascular age-related macular degeneration: Systematic Literature Review and Expert Opinion. Ophthalmology 2020;127:648\u201359.","journal-title":"Ophthalmology"},{"key":"2067_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ajo.2015.01.032","volume":"159","author":"RB Bhisitkul","year":"2015","unstructured":"Bhisitkul RB, Mendes TS, Rofagha S, Enanoria W, Boyer DS, Sadda SR, et al. Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study\u2217. Am J Ophthalmol. 2015;159:915\u201324.","journal-title":"Am J Ophthalmol"},{"key":"2067_CR27","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","volume":"240","author":"U Schl\u00f6tzer-Schrehardt","year":"2002","unstructured":"Schl\u00f6tzer-Schrehardt U, Viestenz A, Naumann GOH, Laqua H, Michels S, Schmidt-Erfurth U. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefe\u2019s Arch Clin Exp Ophthalmol. 2002;240:748\u201357.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"2067_CR28","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3390\/ijms18112468","volume":"18","author":"M Nassisi","year":"2017","unstructured":"Nassisi M, Lavia C, Alovisi C, Musso L, Eandi CM. Short-term choriocapillaris changes in patients with central serous chorioretinopathy after half-dose photodynamic therapy. Int J Mol Sci. 2017;18:2468 https:\/\/doi.org\/10.3390\/ijms18112468","journal-title":"Int J Mol Sci"},{"key":"2067_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","volume":"33","author":"I Bhutto","year":"2012","unstructured":"Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex. Mol Asp Med. 2012;33:295\u2013317.","journal-title":"Mol Asp Med"},{"key":"2067_CR30","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/bjophthalmol-2018-312419","volume":"103","author":"N Miyamoto","year":"2019","unstructured":"Miyamoto N, Mandai M, Oishi A, Nakai S, Honda S, Hirashima T, et al. Long-term results of photodynamic therapy or ranibizumab for polypoidal choroidal vasculopathy in LAPTOP study. Br J Ophthalmol. 2019;103:844\u20138.","journal-title":"Br J Ophthalmol"},{"key":"2067_CR31","doi-asserted-by":"publisher","first-page":"e0229231","DOI":"10.1371\/journal.pone.0229231","volume":"15","author":"K Wataru","year":"2020","unstructured":"Wataru K, Sugiyama A, Yoneyama S, Matsubara M, Fukuda Y, Parikh R, et al. Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy. PLoS ONE. 2020;15:e0229231 https:\/\/doi.org\/10.1371\/journal.pone.0229231","journal-title":"PLoS ONE"},{"key":"2067_CR32","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1097\/IAE.0000000000001323","volume":"37","author":"M Miyata","year":"2017","unstructured":"Miyata M, Hata M, Ooto S, Ogino K, Gotoh N, Morooka S, et al. Choroidal and retinal atrophy of Bietti crystalline dystrophy patients with CYP4V2 mutations compared to retinitis pigmentosa patients with EYS mutations. Retina 2017;37:1193\u2013202.","journal-title":"Retina"},{"key":"2067_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10384-017-0554-5","volume":"62","author":"Y Akagi-Kurashige","year":"2018","unstructured":"Akagi-Kurashige Y, Tsujikawa A, Yuzawa M, Ishibashi T, Nakanishi H, Nakatani E, et al. A 5-year multicenter prospective cohort study on the long-term visual prognosis and predictive factors for visual outcome in Japanese patients with age-related macular degeneration: the AMD2000 study. Jpn J Ophthalmol. 2018;62:137\u201343.","journal-title":"Jpn J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02067-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02067-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02067-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T16:05:10Z","timestamp":1681401910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02067-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02067-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"type":"print","value":"0950-222X"},{"type":"electronic","value":"1476-5454"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors attest that they meet the current ICMJE criteria for authorship.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}